AdaptHealth (AHCO) CTO exercises options and uses shares for tax withholding

Rhea-AI Filing Summary

AdaptHealth Corp. Chief Technology Officer Albert A. Prast exercised employee stock options to acquire 89,451 shares of common stock at $4.38 per share. To cover associated obligations, 58,203 shares of common stock were surrendered at $10.33 per share as a tax-withholding disposition. After these compensation-related transactions, Prast directly owns 474,155 shares of AdaptHealth common stock, reflecting a routine option exercise with part of the shares withheld rather than sold in the open market.

Insights

Equity compensation analyst

CTO exercised options and used shares to cover taxes, with remaining holdings still sizable.

Albert A. Prast, Chief Technology Officer of AdaptHealth Corp., exercised employee stock options covering 89,451 shares of common stock at an exercise price of $4.38 per share. This converted a derivative award into direct share ownership.

On the same date, 58,203 shares of common stock were disposed of at $10.33 per share through a tax-withholding mechanism. This F-code disposition reflects shares withheld to satisfy obligations, not an open-market sale, so it carries limited signaling value about sentiment.

Following these transactions, Prast directly holds 474,155 shares of common stock, with no remaining options from this grant shown. The visible pattern is a standard exercise-plus-tax-withholding event, typical of executive equity compensation rather than a discretionary market trade.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prast Albert A.

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		M		89,451	A	$4.38	532,358	D
Common Stock	03/13/2026		F		58,203	D	$10.33	474,155	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$4.38	03/13/2026		M			89,451	02/01/2021	08/01/2026	Common Stock	89,451	$0	0	D

Explanation of Responses:

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on February 4, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Albert Prast	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AdaptHealth (AHCO) CTO Albert Prast report in this Form 4 filing?

Albert A. Prast reported exercising employee stock options for 89,451 shares of AdaptHealth common stock at $4.38 per share. He then used 58,203 shares, valued at $10.33 each, to cover obligations through a tax-withholding disposition.

How many AdaptHealth shares does CTO Albert Prast own after these transactions?

After the reported transactions, Albert A. Prast directly owns 474,155 shares of AdaptHealth common stock. This figure reflects the net position following the option exercise for 89,451 shares and the tax-withholding disposition of 58,203 shares on the same date.

Were Albert Prast’s AdaptHealth transactions open-market stock sales or tax withholding?

The disposition in this Form 4 is classified as an F-code tax-withholding transaction, not an open-market sale. 58,203 shares were surrendered at $10.33 per share to cover obligations tied to exercising 89,451 stock options.

What type of derivative security did AdaptHealth’s CTO exercise in this Form 4?

Albert A. Prast exercised an Employee Stock Option award, a derivative security giving him the right to buy shares. He converted options covering 89,451 underlying shares of AdaptHealth common stock at an exercise price of $4.38 per share into actual shares.

Does this AdaptHealth Form 4 show any remaining options for Albert Prast from this grant?

The filing indicates that options for 89,451 shares were exercised, and the derivative position tied to this grant shows zero shares remaining. This suggests the reported grant was fully exercised, leaving only direct common stock holdings in this data set.